MedTrace Logo

The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

NCT00596401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-02-21

No results posted yet for this study

Summary

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

Conditions

Sponsors & Collaborators

  • Showa Inan General Hospital

    lead OTHER

Principal Investigators

  • Akira Horiuchi, M.D. · Showa Inan General Hospital

Eligibility

Min Age
19 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00596401 on ClinicalTrials.gov